Geron Drug Patent Portfolio

Geron owns 1 orange book drug protected by 4 US patents Given below is the list of Geron's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US9375485 Use of telomerase inhibitors for the treatment of myeloproliferative disorders and myeloproliferative neoplasms 15 Mar, 2033
Active
US7494982 Modified oligonucleotides for telomerase inhibition 27 Dec, 2025
Active
US9388415 Modified oligonucleotides for telomerase inhibition 09 Sep, 2024 Expired
US9388416 Modified oligonucleotides for telomerase inhibition 09 Sep, 2024 Expired


Geron's Family Patents


Family Patents



Geron Drug List

Given below is the complete list of Geron's drugs and the patents protecting them.


1. Rytelo

Rytelo is protected by 4 patents, out of which 2 have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US9375485 Use of telomerase inhibitors for the treatment of myeloproliferative disorders and myeloproliferative neoplasms 15 Mar, 2033
(8 years from now)
Active
US7494982 Modified oligonucleotides for telomerase inhibition 27 Dec, 2025
(1 year, 13 days from now)
Active
US9388415 Modified oligonucleotides for telomerase inhibition 09 Sep, 2024
(3 months ago)
Expired
US9388416 Modified oligonucleotides for telomerase inhibition 09 Sep, 2024
(3 months ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Rytelo's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Geron News

ST Pharm secures a ₩14 billion contract for the supply of oligonucleotide APIs

26 Jul, 2024

See More